Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
François M. Carlier, Patrick Evrard, Michel Dumonceaux
Abstract
Rights: UNKNOWN · cc-by-nc-nd · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cytomegalovirus in solid organ transplantation
10.1111/ajt.12103 · 2013
Cytomegalovirus infection in transplant recipients
10.6061/clinics/2015(07)09 · 2015
New developments in the management of cytomegalovirus infection after transplantation
10.1007/s40265-018-0943-1 · 2018
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
10.1111/j.1600-6143.2004.00382.x · 2004
Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials
10.1093/cid/ciw668 · 2017
Cytomegalovirus infection in kidney allografts: a review of literature
10.21037/tau.2018.10.14 · 2019
Cytomegalovirus nephritis in kidney transplant recipients: epidemiology and outcomes of an uncommon diagnosis
10.1111/tid.13702 · 2021
No additional external references are available.